AI assistant
Q32 Bio Inc. — Director's Dealing 2024
Aug 14, 2024
34891_dirs_2024-08-14_17d38498-1d0c-491e-9753-4eb9d5e2af59.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Q32 Bio Inc. (QTTB)
CIK: 0001661998
Period of Report: 2024-03-25
Reporting Person: TZIANABOS ARTHUR (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-25 | Common Stock | M | 1095 | — | Acquired | 8248 | Direct |
| 2024-03-25 | Common Stock | S | 265 | $24.20 | Disposed | 7983 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-03-25 | Restricted Stock Units | $ | M | 1095 | Disposed | Common Stock (1095) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Issuer Common Stock.
F2: The Issuer effected a 1-for-18 reverse stock split of its Common Stock on March 25, 2024. The amounts reported on this Form 4 have been adjusted to reflect the reverse stock split.
F3: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
F4: The restricted stock units vested in three equal installments, with the final installment vested on March 25, 2024. The restricted stock units had no expiration date.